CL2016000836A1 - Composiciones de péptidos nuevas. - Google Patents

Composiciones de péptidos nuevas.

Info

Publication number
CL2016000836A1
CL2016000836A1 CL2016000836A CL2016000836A CL2016000836A1 CL 2016000836 A1 CL2016000836 A1 CL 2016000836A1 CL 2016000836 A CL2016000836 A CL 2016000836A CL 2016000836 A CL2016000836 A CL 2016000836A CL 2016000836 A1 CL2016000836 A1 CL 2016000836A1
Authority
CL
Chile
Prior art keywords
peptide compositions
new peptide
new
compositions
peptide
Prior art date
Application number
CL2016000836A
Other languages
English (en)
Spanish (es)
Inventor
Richard Franklin
Original Assignee
Tarix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tarix Pharmaceuticals Ltd filed Critical Tarix Pharmaceuticals Ltd
Publication of CL2016000836A1 publication Critical patent/CL2016000836A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CL2016000836A 2013-10-11 2016-04-11 Composiciones de péptidos nuevas. CL2016000836A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361890056P 2013-10-11 2013-10-11
US201461940095P 2014-02-14 2014-02-14

Publications (1)

Publication Number Publication Date
CL2016000836A1 true CL2016000836A1 (es) 2016-09-16

Family

ID=52813728

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000836A CL2016000836A1 (es) 2013-10-11 2016-04-11 Composiciones de péptidos nuevas.

Country Status (14)

Country Link
US (2) US9133241B2 (enExample)
EP (1) EP3054967A4 (enExample)
JP (1) JP2017501967A (enExample)
KR (1) KR20160065969A (enExample)
CN (1) CN105828831A (enExample)
AU (1) AU2014332346B2 (enExample)
BR (1) BR112016007816A2 (enExample)
CA (1) CA2926641A1 (enExample)
CL (1) CL2016000836A1 (enExample)
IL (1) IL244956B (enExample)
MX (1) MX2016004660A (enExample)
RU (1) RU2016112931A (enExample)
SG (1) SG11201602661PA (enExample)
WO (1) WO2015054006A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017150327A1 (ja) * 2016-03-03 2017-09-08 不二製油グループ本社株式会社 神経栄養因子の脳内分泌促進するための食品添加用組成物
JP6983247B2 (ja) * 2017-02-16 2021-12-17 ケアジェン カンパニー, リミテッドCaregen Co., Ltd. サリチル酸とペプチドとの結合体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244946A (en) 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4305872A (en) 1979-10-19 1981-12-15 Kenneth Wingrove Polypeptide derivatives
US4316891A (en) 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
US20020168761A1 (en) 2000-01-24 2002-11-14 Gour Barbara J. Peptidomimetic modulators of cell adhesion
WO1998002452A2 (en) 1996-07-12 1998-01-22 Mcgill University Compounds and methods for modulating cell adhesion
US7563862B2 (en) 2001-08-24 2009-07-21 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods for their use in treatment of brain damage
WO2003018754A2 (en) 2001-08-24 2003-03-06 Neuronz Limited Neural regeneration peptide and methods for their use in treatment of brain damage
AU2003293807A1 (en) * 2002-12-24 2004-07-22 Algonomics N.V. Mhc class i restricted t-cell stimulating peptides from hepatitis b virus
WO2005042561A2 (en) 2003-10-31 2005-05-12 Neuren Pharmaceuticals Limited Neural regeneration peptides and methods of use
WO2007011595A2 (en) * 2005-07-15 2007-01-25 Neuren Pharmaceuticals Limited Neural regeneration peptides and antioxidants protect neurons from degeneration
AU2011274474B2 (en) * 2010-07-09 2015-06-18 Dana-Farber Cancer Institute, Inc. Stabilized insulinotropic peptides and methods of use
US20130210726A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease

Also Published As

Publication number Publication date
CA2926641A1 (en) 2015-04-16
BR112016007816A2 (pt) 2017-12-05
WO2015054006A2 (en) 2015-04-16
RU2016112931A3 (enExample) 2018-06-20
AU2014332346B2 (en) 2019-01-24
IL244956B (en) 2019-10-31
RU2016112931A (ru) 2017-11-16
US20170275333A1 (en) 2017-09-28
WO2015054006A3 (en) 2015-06-04
EP3054967A2 (en) 2016-08-17
JP2017501967A (ja) 2017-01-19
US9133241B2 (en) 2015-09-15
SG11201602661PA (en) 2016-05-30
AU2014332346A1 (en) 2016-05-05
MX2016004660A (es) 2016-11-14
IL244956A0 (en) 2016-05-31
EP3054967A4 (en) 2017-04-19
US20150105335A1 (en) 2015-04-16
KR20160065969A (ko) 2016-06-09
CN105828831A (zh) 2016-08-03

Similar Documents

Publication Publication Date Title
CL2016000258A1 (es) Composiciones edulcorantes.
CL2016000257A1 (es) Composiciones edulcorantes.
CL2015003031A1 (es) Compuesto peptídico
FR3006466B3 (fr) .
CL2016000680A1 (es) Formulaciones de anticuerpos anti-pdl1.
DK2986726T3 (da) Hidtil ukendte bacillusstammesammensætninger
EP3023461A4 (en) SEALING COMPOSITION
EP2889350A4 (en) ADHESIVE COMPOSITION
BR112016010220A2 (pt) compostos inibidores de autoxatina.
EP2989885A4 (en) HARVESTER
BR112015021295A2 (pt) composição de dois componentes.
DK3027750T3 (da) Biokatalytisk sammensætning
HRP20181213T1 (hr) Peptidna smjesa
PL2994154T3 (pl) Peptyd antydrobnoustrojowy
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
FR3007636B1 (fr) Trocart perforant.
EP2999689A4 (en) Cyanoacrylate compositions
LT3030259T (lt) Peptidai
FR3001302B1 (fr) .
BR112016010562A2 (pt) composição antitranspirante.
EP2959776A4 (en) HERBICIDE COMPOSITION
KR20180085014A (ko) 펩티드 조성물
EP3060191C0 (en) A dispenser
FR3006896B1 (fr) Composition photoprotectrice
IL244956B (en) Novel peptide compositions